首页 > 最新文献

Eurasian Journal of Medicine最新文献

英文 中文
Clinical Approach and Anatomical Results in the Treatment of Retinopathy of Prematurity. 治疗早产儿视网膜病变的临床方法和解剖结果。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-02-01 DOI: 10.5152/eurasianjmed.2024.23140
Mustafa Yıldırım

Background:  Retinopathy of prematurity (ROP) is a disease associated with abnormal development of retinal vessels in low birth weight and preterm infants. In this study, it was aimed to show that the disease can be controlled almost perfectly with early diagnosis and treatment in retinopathy developing in premature babies.

Methods:  In the study, 66 eyes of 33 patients who needed ROP treatment were evaluated. Babies who met the screening criteria were examined for the first time 3-4 weeks after birth. In the treatment of patients who underwent laser photocoagulation and intravitreal injection, the stage of the disease plus the regression of the disease in the laser group and completion of retinal vascularization in the intravitreal injection group were determined as success criteria.

Results:  Laser photocoagulation (LFC) was applied to 54 eyes, intravitreal bevacizumab (IVB) was applied to 8 eyes, and bilateral LFC+IVB was applied to 2 patients in the same session. Since there was no complete regression in the stage of the 2 patients who underwent LFC, an IVB injection was made into one eye of a patient and both eyes of the other patient. After the treatments, the disease regressed and retinal macular traction did not occur.

Conclusion:  It has been indicated that timely intervention in patients with treatment indications after regular screening for ROP can prevent possible blindness.

背景: 早产儿视网膜病变(ROP)是一种与低出生体重儿和早产儿视网膜血管发育异常有关的疾病。本研究旨在证明,早产儿视网膜病变的早期诊断和治疗几乎可以完全控制该疾病: 研究对 33 名需要接受视网膜病变治疗的患者的 66 只眼睛进行了评估。符合筛查标准的婴儿在出生后 3-4 周接受首次检查。在对接受激光光凝和玻璃体内注射治疗的患者进行治疗时,将疾病的分期以及激光组疾病的消退和玻璃体内注射组视网膜血管形成的完成情况作为成功的标准: 结果:54只眼睛接受了激光光凝治疗,8只眼睛接受了静脉注射贝伐单抗治疗,2名患者在同一疗程中接受了双侧激光光凝+静脉注射贝伐单抗治疗。由于接受 LFC 治疗的 2 名患者的病情没有完全缓解,因此对其中一名患者的单眼和另一名患者的双眼进行了 IVB 注射。治疗后,病情有所缓解,视网膜黄斑牵引也没有发生: 结论:这表明,在定期筛查 ROP 后,对有治疗指征的患者进行及时干预,可避免可能的失明。
{"title":"Clinical Approach and Anatomical Results in the Treatment of Retinopathy of Prematurity.","authors":"Mustafa Yıldırım","doi":"10.5152/eurasianjmed.2024.23140","DOIUrl":"10.5152/eurasianjmed.2024.23140","url":null,"abstract":"<p><strong>Background: </strong> Retinopathy of prematurity (ROP) is a disease associated with abnormal development of retinal vessels in low birth weight and preterm infants. In this study, it was aimed to show that the disease can be controlled almost perfectly with early diagnosis and treatment in retinopathy developing in premature babies.</p><p><strong>Methods: </strong> In the study, 66 eyes of 33 patients who needed ROP treatment were evaluated. Babies who met the screening criteria were examined for the first time 3-4 weeks after birth. In the treatment of patients who underwent laser photocoagulation and intravitreal injection, the stage of the disease plus the regression of the disease in the laser group and completion of retinal vascularization in the intravitreal injection group were determined as success criteria.</p><p><strong>Results: </strong> Laser photocoagulation (LFC) was applied to 54 eyes, intravitreal bevacizumab (IVB) was applied to 8 eyes, and bilateral LFC+IVB was applied to 2 patients in the same session. Since there was no complete regression in the stage of the 2 patients who underwent LFC, an IVB injection was made into one eye of a patient and both eyes of the other patient. After the treatments, the disease regressed and retinal macular traction did not occur.</p><p><strong>Conclusion: </strong> It has been indicated that timely intervention in patients with treatment indications after regular screening for ROP can prevent possible blindness.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"56 1","pages":"52-55"},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study. 超声引导筋膜间注射与物理疗法相结合对慢性腰痛的疗效:一项准实验研究。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-02-01 DOI: 10.5152/eurasianjmed.2024.23286
Burcu Metin Ökmen, Korgün Ökmen

Background:  Anatomical and histological features of the thoracolumbar fascia may play an active role in chronic low back pain (LBP). This study aimed to evaluate the efcacy of interfascial injection in patients with LBP.

Methods:  Sixty participants with chronic LBP were recruited for this study. The patients were allocated to 2 groups: physical therapy (PT) (n=30) and PT+interfascial injection (IFI) (n=31, 10mL (0.25% bupivacaine)+methylprednisolone (40 mg) injection into the middle layer between the quadratus lumborum and erector spinae muscle). Outcome measures involved performing Numeric Rating Scale (NRS) and Oswestry Disability Index (ODI) scoring on study participants at pretreatment (PRT), as well as posttreatment at months first, second, fourth, and sixth.

Results:  In both groups, NRS and ODI scores were statistically significantly lower than PRT values at the first, second, third, fourth, and sixth months. (P <.05) NRS and ODI scores were significantly lower in the IFI and PT groups compared to the PT group at the first, second, fourth, and sixth months. (P <.05).

Conclusion:  The study result shows that IFI applied to the middle layer of the thoracolumbar fascia may be efective in individuals with chronic LBP. The efect of fascial structures on LBP should be further investigated.

背景: 胸腰椎筋膜的解剖学和组织学特征可能在慢性腰背痛(LBP)中发挥着积极作用。本研究旨在评估筋膜间注射对腰背痛患者的疗效: 本研究招募了 60 名慢性腰背痛患者。患者被分为两组:物理治疗组(30 人)和物理治疗+筋膜间注射组(31 人,在腰四头肌和竖脊肌之间的中间层注射 10 毫升(0.25% 布比卡因)+ 甲基强的松龙(40 毫克))。结果测量包括在治疗前(PRT)以及治疗后第一、第二、第四和第六个月对研究参与者进行数值评定量表(NRS)和Oswestry残疾指数(ODI)评分: 两组患者在治疗后第一、第二、第三、第四和第六个月的 NRS 和 ODI 评分均明显低于 PRT 值。(P 结论 研究结果表明,在胸腰部筋膜中层应用 IFI 对慢性腰痛患者可能有效。应进一步研究筋膜结构对枸杞痛的影响。
{"title":"Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study.","authors":"Burcu Metin Ökmen, Korgün Ökmen","doi":"10.5152/eurasianjmed.2024.23286","DOIUrl":"10.5152/eurasianjmed.2024.23286","url":null,"abstract":"<p><strong>Background: </strong> Anatomical and histological features of the thoracolumbar fascia may play an active role in chronic low back pain (LBP). This study aimed to evaluate the efcacy of interfascial injection in patients with LBP.</p><p><strong>Methods: </strong> Sixty participants with chronic LBP were recruited for this study. The patients were allocated to 2 groups: physical therapy (PT) (n=30) and PT+interfascial injection (IFI) (n=31, 10mL (0.25% bupivacaine)+methylprednisolone (40 mg) injection into the middle layer between the quadratus lumborum and erector spinae muscle). Outcome measures involved performing Numeric Rating Scale (NRS) and Oswestry Disability Index (ODI) scoring on study participants at pretreatment (PRT), as well as posttreatment at months first, second, fourth, and sixth.</p><p><strong>Results: </strong> In both groups, NRS and ODI scores were statistically significantly lower than PRT values at the first, second, third, fourth, and sixth months. (P <.05) NRS and ODI scores were significantly lower in the IFI and PT groups compared to the PT group at the first, second, fourth, and sixth months. (P <.05).</p><p><strong>Conclusion: </strong> The study result shows that IFI applied to the middle layer of the thoracolumbar fascia may be efective in individuals with chronic LBP. The efect of fascial structures on LBP should be further investigated.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"56 1","pages":"56-60"},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Bacteriocins on the Intestinal Microbiota. 细菌素对肠道微生物群的影响
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-12-01 DOI: 10.5152/eurasianjmed.2023.23393
Selin Doğan, Taha Yasin Koç, Mehmet Karadayı

Intestinal microbiota, which plays an important role in human health by interacting with each other or with its hosts, is afected by many endogenous and exogenous factors. Any change in the composition and functionality of the intestinal microbiota, both in number and diversity, causes disruption of intestinal functioning and paves the way for many diseases. In this regard, many antimicrobial peptides, especially bacteriocins, synthesized by lactic acid bacteria are thought to be natural resources with a high potential for the protection of the intestinal microbiota and the treatment of intestinal diseases. Both the intestinal microbiota itself and many foodborne bacteria produce bacteriocins that can inhibit pathogenic microorganisms that cause serious health problems and regulate the intestinal microbiota. This review aims to provide a comprehensive overview of the intestinal microbiota, the properties of lactic acid bacteria, their bacteriocins, and the efects of bacteriocins on the human health.

肠道微生物群通过相互之间或与宿主之间的相互作用,在人类健康中发挥着重要作用,它受到许多内源性和外源性因素的影响。肠道微生物群的组成和功能(包括数量和多样性)的任何变化都会导致肠道功能紊乱,并为多种疾病的发生铺平道路。在这方面,乳酸菌合成的许多抗菌肽,特别是细菌素,被认为是保护肠道微生物群和治疗肠道疾病的天然资源,具有很大的潜力。肠道微生物区系本身和许多食源性细菌都能产生细菌素,这些细菌素能抑制导致严重健康问题的病原微生物,并能调节肠道微生物区系。本综述旨在全面概述肠道微生物群、乳酸菌的特性、其细菌素以及细菌素对人类健康的影响。
{"title":"Effect of Bacteriocins on the Intestinal Microbiota.","authors":"Selin Doğan, Taha Yasin Koç, Mehmet Karadayı","doi":"10.5152/eurasianjmed.2023.23393","DOIUrl":"10.5152/eurasianjmed.2023.23393","url":null,"abstract":"<p><p>Intestinal microbiota, which plays an important role in human health by interacting with each other or with its hosts, is afected by many endogenous and exogenous factors. Any change in the composition and functionality of the intestinal microbiota, both in number and diversity, causes disruption of intestinal functioning and paves the way for many diseases. In this regard, many antimicrobial peptides, especially bacteriocins, synthesized by lactic acid bacteria are thought to be natural resources with a high potential for the protection of the intestinal microbiota and the treatment of intestinal diseases. Both the intestinal microbiota itself and many foodborne bacteria produce bacteriocins that can inhibit pathogenic microorganisms that cause serious health problems and regulate the intestinal microbiota. This review aims to provide a comprehensive overview of the intestinal microbiota, the properties of lactic acid bacteria, their bacteriocins, and the efects of bacteriocins on the human health.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"55 1","pages":"165-169"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Shining Star of the Last Decade in Regional Anesthesia Part-II: Interfascial Plane Blocks for Cardiac, Abdominal, and Spine Surgery. 区域麻醉十年来的耀眼之星第二部分:心脏、腹部和脊椎手术的科间平面阻滞。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-02 DOI: 10.5152/eurasianjmed.2023.23015
Ahmet Murat Yayık, Erkan Cem Çelik, Muhammed Enes Aydın, Elif Oral Ahıskalıoğlu, Burhan Dost, Başak Altıparmak, Madan Narayanan, Alessandro De Cassai, Serkan Tulgar, Ali Ahıskalıoğlu

The sine qua non of enhanced recovery after surgery protocols designed to improve the perioperative experiences and outcomes of patients is to determine the most appropriate analgesia management. Although many regional techniques have been tried over the years in this purpose, interfacial plane blocks have become more popular with the introduction of ultrasound technology into daily practice and they have great potential to support effective postoperative pain management in many surgeries. The current article focuses on the benefits, techniques, indications, and complications of interfascial plane blocks applied in cardiac, abdominal, and spine surgeries.

旨在改善患者围手术期体验和结果的术后恢复方案的必要条件是确定最合适的镇痛管理。尽管多年来已经尝试了许多区域性技术,但随着超声技术在日常实践中的引入,界面平面块变得越来越受欢迎,它们在许多手术中具有支持有效术后疼痛管理的巨大潜力。目前的文章重点介绍了在心脏、腹部和脊椎手术中应用筋膜间平面阻滞的益处、技术、适应症和并发症。
{"title":"The Shining Star of the Last Decade in Regional Anesthesia Part-II: Interfascial Plane Blocks for Cardiac, Abdominal, and Spine Surgery.","authors":"Ahmet Murat Yayık, Erkan Cem Çelik, Muhammed Enes Aydın, Elif Oral Ahıskalıoğlu, Burhan Dost, Başak Altıparmak, Madan Narayanan, Alessandro De Cassai, Serkan Tulgar, Ali Ahıskalıoğlu","doi":"10.5152/eurasianjmed.2023.23015","DOIUrl":"10.5152/eurasianjmed.2023.23015","url":null,"abstract":"<p><p>The sine qua non of enhanced recovery after surgery protocols designed to improve the perioperative experiences and outcomes of patients is to determine the most appropriate analgesia management. Although many regional techniques have been tried over the years in this purpose, interfacial plane blocks have become more popular with the introduction of ultrasound technology into daily practice and they have great potential to support effective postoperative pain management in many surgeries. The current article focuses on the benefits, techniques, indications, and complications of interfascial plane blocks applied in cardiac, abdominal, and spine surgeries.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Capitonnage and Uncapitonnage Techniques for Pulmonary Hydatid Cysts: A Systematic Review and Meta-analysis. 肺棘球蚴囊顶切除术和非囊顶切除技术的比较:系统综述和荟萃分析。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-02 DOI: 10.5152/eurasianjmed.2023.22281
Yener Aydın, Kamber Kasalı, Ali Bilal Ulaş, Ayşenur Dostbil, İlker İnce, Atilla Eroglu

Surgery is the primary treatment for pulmonary hydatid cysts. This systematic review and meta-analysis aimed to compare the results of capitonnage and uncapitonnage techniques for the surgery of pulmonary hydatid cysts. Descriptive Boolean queries were used to search PubMed, Scopus, and Web of Science for articles published up to June 2022 to evaluate the outcomes of pulmonary hydatid cysts in terms of mortality, postoperative complications, and hospital stay. A total of 12 studies were included. An analysis of the total side effects revealed that there was a statistically significant difference between the capitonnage and uncapitonnage groups (odds ratio=3.81, 95% confidence interval=[1.75-8.31], P < .001). The results showed that more side effects were observed in the uncapitonnage group than in the capitonnage group. The risk of side effects in the uncapitonnage group is 3.81 times higher than in the capitonnage group. The results showed that more prolonged air leak was seen in uncapitonnage group than in the capitonnage group (odds ratio=4.18, 95% confidence interval=[1.64-10.64], P=.003). The results show that more empyema was observed in uncapitonnage group than in the capitonnage group (odds ratio=4.76, 95% confidence interval=[1.29-17.57], P =0.020). An analysis of atelectasis and mean hospital stay revealed that there was no statistically significant difference between the capitonnage and uncapitonnage groups. The results reveal the advantages of capitonnage in the treatment of pulmonary hydatid cysts and that the capitonnage method is quite effective in reducing complications compared to the uncapitonnage method.

手术是治疗肺棘球蚴的主要方法。本系统综述和荟萃分析旨在比较头切除和非头切除技术在肺棘球蚴囊肿手术中的结果。描述性布尔查询用于搜索PubMed、Scopus和Web of Science,查找截至2022年6月发表的文章,以评估肺棘球蚴病的死亡率、术后并发症和住院时间。共纳入12项研究。对总副作用的分析显示,头型和非头型组之间存在统计学上的显著差异(比值比=3.81,95%置信区间=[1.75-8.31],P<.001)。结果显示,未头型组的副作用比头型组多。非妊娠组的副作用风险是妊娠组的3.81倍。结果显示,无胸组的漏气时间比头戴组长(比值比=4.18,95%置信区间=[1.64-10.64],P=0.003)。结果显示,与头戴组相比,无胸的脓胸次数更多(比值比4.76,95%可信区间=[1.29-17.57],P=0.020)。肺不张与平均住院时间的分析结果显示,头颈部和非头颈部组之间没有统计学上的显著差异。结果显示了头状切除术在治疗肺棘球蚴病中的优势,并且与非头状切除法相比,头状切除方法在减少并发症方面相当有效。
{"title":"Comparing Capitonnage and Uncapitonnage Techniques for Pulmonary Hydatid Cysts: A Systematic Review and Meta-analysis.","authors":"Yener Aydın, Kamber Kasalı, Ali Bilal Ulaş, Ayşenur Dostbil, İlker İnce, Atilla Eroglu","doi":"10.5152/eurasianjmed.2023.22281","DOIUrl":"10.5152/eurasianjmed.2023.22281","url":null,"abstract":"<p><p>Surgery is the primary treatment for pulmonary hydatid cysts. This systematic review and meta-analysis aimed to compare the results of capitonnage and uncapitonnage techniques for the surgery of pulmonary hydatid cysts. Descriptive Boolean queries were used to search PubMed, Scopus, and Web of Science for articles published up to June 2022 to evaluate the outcomes of pulmonary hydatid cysts in terms of mortality, postoperative complications, and hospital stay. A total of 12 studies were included. An analysis of the total side effects revealed that there was a statistically significant difference between the capitonnage and uncapitonnage groups (odds ratio=3.81, 95% confidence interval=[1.75-8.31], P < .001). The results showed that more side effects were observed in the uncapitonnage group than in the capitonnage group. The risk of side effects in the uncapitonnage group is 3.81 times higher than in the capitonnage group. The results showed that more prolonged air leak was seen in uncapitonnage group than in the capitonnage group (odds ratio=4.18, 95% confidence interval=[1.64-10.64], P=.003). The results show that more empyema was observed in uncapitonnage group than in the capitonnage group (odds ratio=4.76, 95% confidence interval=[1.29-17.57], P =0.020). An analysis of atelectasis and mean hospital stay revealed that there was no statistically significant difference between the capitonnage and uncapitonnage groups. The results reveal the advantages of capitonnage in the treatment of pulmonary hydatid cysts and that the capitonnage method is quite effective in reducing complications compared to the uncapitonnage method.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis Lichenoides et Varioliformis Acuta Case with Enterobiasis, Giardiasis, and Helicobacter pylori Infection. 尖锐苔藓样和Varioliformis糠疹合并肠病、贾第鞭毛虫病和幽门螺杆菌感染病例。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-27 DOI: 10.5152/eurasianjmed.2023.23026
Mehmet Melikoğlu, Büşra Solak Esen, Rabia Yamak, Ali İşlek
{"title":"Pityriasis Lichenoides et Varioliformis Acuta Case with Enterobiasis, Giardiasis, and Helicobacter pylori Infection.","authors":"Mehmet Melikoğlu, Büşra Solak Esen, Rabia Yamak, Ali İşlek","doi":"10.5152/eurasianjmed.2023.23026","DOIUrl":"10.5152/eurasianjmed.2023.23026","url":null,"abstract":"","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54232173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in the Urethral Artery After Experimental Subarachnoid Hemorrhage-Induced Injury of the Pudendal Ganglion and Onuf’s Nucleus Junction 实验性蛛网膜下腔出血致阴部神经节及Onuf核连接处损伤后尿道动脉的变化
Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-26 DOI: 10.5152/eurasianjmed.2023.23202
{"title":"Changes in the Urethral Artery After Experimental Subarachnoid Hemorrhage-Induced Injury of the Pudendal Ganglion and Onuf’s Nucleus Junction","authors":"","doi":"10.5152/eurasianjmed.2023.23202","DOIUrl":"https://doi.org/10.5152/eurasianjmed.2023.23202","url":null,"abstract":"","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134907556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Relationship Between Oral Health and Body Mass Index. 口腔健康与体重指数关系的评价。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-01 DOI: 10.5152/eurasianjmed.2023.23272
Zeynep Betül Arslan

Objective: The objectives of this study is to evaluate oral health comparatively in four different groups separated according to body mass index (BMI).

Materials and methods: A total of 352 patients who applied for different dental reasons were divided into groups according to BMI and examined radiologically. The incidence of oral health parameters (dental caries, alveolar bone loss, tooth loss, and periapical lesion) was evaluated.

Results: While there was a significant difference between the groups in terms of caries, alveolar bone loss, and tooth loss (P < .05), there was no difference in the incidence of periapical lesions (P > .05).

Conclusion: Obese individuals have a higher prevalence of alveolar bone loss, caries, and tooth loss. These results show that an above-normal BMI is an important factor that can negatively affect oral health.

目的:本研究的目的是比较评估根据身体质量指数(BMI)划分的四个不同组的口腔健康状况。材料和方法:共有352名因不同牙科原因申请的患者根据BMI分为两组,并进行放射学检查。评估口腔健康参数(龋齿、牙槽骨缺失、牙齿缺失和根尖周病变)的发生率。结果:虽然两组在龋齿、牙槽骨丢失和牙齿丢失方面有显著差异(P<0.05),但根尖周病变的发生率没有差异(P>0.05)。结论:肥胖个体的牙槽骨丢失、龋齿和牙齿丢失的发生率较高。这些结果表明,高于正常水平的BMI是一个可能对口腔健康产生负面影响的重要因素。
{"title":"Evaluation of the Relationship Between Oral Health and Body Mass Index.","authors":"Zeynep Betül Arslan","doi":"10.5152/eurasianjmed.2023.23272","DOIUrl":"10.5152/eurasianjmed.2023.23272","url":null,"abstract":"<p><strong>Objective: </strong>The objectives of this study is to evaluate oral health comparatively in four different groups separated according to body mass index (BMI).</p><p><strong>Materials and methods: </strong>A total of 352 patients who applied for different dental reasons were divided into groups according to BMI and examined radiologically. The incidence of oral health parameters (dental caries, alveolar bone loss, tooth loss, and periapical lesion) was evaluated.</p><p><strong>Results: </strong>While there was a significant difference between the groups in terms of caries, alveolar bone loss, and tooth loss (P < .05), there was no difference in the incidence of periapical lesions (P > .05).</p><p><strong>Conclusion: </strong>Obese individuals have a higher prevalence of alveolar bone loss, caries, and tooth loss. These results show that an above-normal BMI is an important factor that can negatively affect oral health.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"55 3","pages":"259-262"},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children. Sugammadex在七氟醚和地氟醚麻醉下逆转罗库诱导的儿童神经肌肉阻滞。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-01 DOI: 10.5152/eurasianjmed.2022.22090
Gamze Pirinç Şaşıoğlu, Pınar Kendigelen, Ayşe Çiğdem Tütüncü, Güner Kaya

Objective: In children, neuromuscular blockers may have different effects with various inhalation agents and incomplete reversal of the blockade continues to be a problem. The aim of the study is to observe the effects of sugammadex on reversing the blockade by a single dose of rocuronium, the peak inspiratory pressure, hemodynamic parameters in children under sevoflurane and desflurane anesthesia.

Materials and methods: One hundred forty-eight children aged 2-10 years old, to be operated under shortterm general anesthesia, were enrolled in this prospective randomized controlled trial. After induction, the patients were intubated at the end of TOF (Train-of-four) ratio of 1.0-0. The time taken until TOF reached 0.25 was recorded, and 2 mg/kg sugammadex was administered to the patients. The period until the TOF was at least 0.9 and in the first 10 minutes after sugammadex injection, peak inspiratory pressure, the systolic-diastolic arterial pressure, and the heart rate were monitored and possible side effects were observed in the recovery room.

Results: Following the injection of sugammadex, the time taken for TOF of 0.25 to reach >0.9 was significantly shorter in the 2-4-year-old age group under sevoflurane anesthesia. After sugammadex injection, a small but statistically significant increase in peak inspiratory pressure values was observed in Group D at the 2nd, 5th, and 10th minutes.

Conclusion: Rapid and complete recovery was achieved from the block induced by a single dose of 0.6 mg/ kg rocuronium by the use of sugammadex which did not give rise to any side effects.

目的:在儿童中,神经肌肉阻滞剂可能与各种吸入剂有不同的效果,并且阻断剂的不完全逆转仍然是一个问题。本研究的目的是观察sugammadex逆转单剂量罗库阻滞的效果、儿童在七氟醚和地氟醚麻醉下的峰值吸气压力、血液动力学参数。材料和方法:148名2-10岁的儿童在短期全身麻醉下接受手术,纳入这项前瞻性随机对照试验。诱导后,患者在TOF(四列)比率为1.0-0时插管。记录TOF达到0.25所需的时间,并给患者服用2 mg/kg sugammadex。TOF至少为0.9之前,在sugammadex注射后的前10分钟,监测吸气峰值、收缩-舒张动脉压和心率,并在恢复室观察可能的副作用。结果:sugammadex注射后,在七氟醚麻醉下,2-4岁年龄组TOF从0.25到>0.9的时间明显缩短。sugammadex注射后,D组在第2、第5和第10分钟的吸气压力峰值略有增加,但具有统计学意义。结论:单次0.6 mg/kg罗库阻滞后,sugammadex可快速完全恢复,无任何副作用。
{"title":"Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children.","authors":"Gamze Pirinç Şaşıoğlu, Pınar Kendigelen, Ayşe Çiğdem Tütüncü, Güner Kaya","doi":"10.5152/eurasianjmed.2022.22090","DOIUrl":"10.5152/eurasianjmed.2022.22090","url":null,"abstract":"<p><strong>Objective: </strong>In children, neuromuscular blockers may have different effects with various inhalation agents and incomplete reversal of the blockade continues to be a problem. The aim of the study is to observe the effects of sugammadex on reversing the blockade by a single dose of rocuronium, the peak inspiratory pressure, hemodynamic parameters in children under sevoflurane and desflurane anesthesia.</p><p><strong>Materials and methods: </strong>One hundred forty-eight children aged 2-10 years old, to be operated under shortterm general anesthesia, were enrolled in this prospective randomized controlled trial. After induction, the patients were intubated at the end of TOF (Train-of-four) ratio of 1.0-0. The time taken until TOF reached 0.25 was recorded, and 2 mg/kg sugammadex was administered to the patients. The period until the TOF was at least 0.9 and in the first 10 minutes after sugammadex injection, peak inspiratory pressure, the systolic-diastolic arterial pressure, and the heart rate were monitored and possible side effects were observed in the recovery room.</p><p><strong>Results: </strong>Following the injection of sugammadex, the time taken for TOF of 0.25 to reach >0.9 was significantly shorter in the 2-4-year-old age group under sevoflurane anesthesia. After sugammadex injection, a small but statistically significant increase in peak inspiratory pressure values was observed in Group D at the 2nd, 5th, and 10th minutes.</p><p><strong>Conclusion: </strong>Rapid and complete recovery was achieved from the block induced by a single dose of 0.6 mg/ kg rocuronium by the use of sugammadex which did not give rise to any side effects.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"55 3","pages":"173-177"},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role and Antagonistic Effects of miR-16-5p in the Regulation of ADP-Ribosylation Factor-Like Tumor Suppressor Gene 1 in Lung Cancer Cells. miR-16-5p在调节肺癌症细胞ADP-核糖基化因子样肿瘤抑制基因1中的作用和拮抗作用。
IF 1.5 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-01 DOI: 10.5152/eurasianjmed.2023.23073
Tuğba Nurcan Yüksel, Esra Bozgeyik, İbrahim Bozgeyik

Objective: ADP-ribosylation factor-like tumor suppressor gene 1 is a member of the Ras superfamily of small guanosine triphosphatases that are known to be involved in multiple regulatory pathways in the multistage development of human cancers. Also, ADP-ribosylation factor-like tumor suppressor gene 1 expression levels have been reported to be dramatically lower in both cancer cell lines and tumor tissues compared to controls. Accordingly, defects in the regulation of the ADP-ribosylation factor-like tumor suppressor gene 1 gene seems have key tumor suppressive effects in the formation and development of human cancers including lung cancer. Moreover, microRNAs regulating the expression of ADP-ribosylation factor-like tumor suppressor gene 1 have not been described previously. Accordingly, the present study aimed to reveal the influence of miR-16-5p on the regulation of ADP-ribosylation factor-like tumor suppressor gene 1 gene.

Materials and methods: A549 lung adenocarcinoma cells were used. For the overexpression and silencing experiments of miR-16-5p synthetic microRNA mimics and inhibitors were used, respectively. Gene expression analyses were achieved with the help of quantitative real-time polymerase chain reaction.

Results: MiR-16-5p was identified to be predictive target of ADP-ribosylation factor-like tumor suppressor gene 1 and directly targets the expression of ADP-ribosylation factor-like tumor suppressor gene 1 as revealed by the overexpression and silencing experiments. Specifically, it was found that miR-16-5p-overexpressed A549 cells showed a decrease in ADP-ribosylation factor-like tumor suppressor gene 1 gene expression, whereas miR16-5p-suppressed cells showed an increase in expression. These findings possibly suggest that miR-16-5p is the direct regulatory microRNA that posttranscriptionally regulates the expression of ADP-ribosylation factor-like tumor suppressor gene 1.

Conclusion: Collectively, miR-16-5p seems to be a key regulatory molecule involved in the posttranscriptional regulation of the ADP-ribosylation factor-like tumor suppressor gene 1, and it might be responsible for the downregulation of this gene in lung cancer.

目的:ADP-核糖基化因子样肿瘤抑制基因1是小鸟苷三磷酸酶Ras超家族的成员,已知其参与人类癌症多阶段发展的多种调节途径。此外,据报道,与对照相比,在癌症细胞系和肿瘤组织中,ADP-核糖基化因子样肿瘤抑制基因1的表达水平显著降低。因此,ADP-核糖基化因子样肿瘤抑制基因1基因的调节缺陷似乎在包括癌症在内的人类癌症的形成和发展中具有关键的肿瘤抑制作用。此外,调节ADP-核糖基化因子样肿瘤抑制基因1表达的微小RNA以前没有描述过。因此,本研究旨在揭示miR-16-5p对ADP-核糖基化因子样肿瘤抑制基因1基因调控的影响。材料与方法:采用A549肺腺癌细胞。对于miR-16-5p的过表达和沉默实验,分别使用合成的微小RNA模拟物和抑制剂。基因表达分析是在定量实时聚合酶链式反应的帮助下实现的。结果:MiR-16-5p被鉴定为ADP核糖基化因子样抑癌基因1的预测靶点,并通过过表达和沉默实验直接靶向ADP核糖基因子样抑瘤基因1的表达。具体而言,发现miR-16-5p过表达的A549细胞显示出ADP核糖基化因子样肿瘤抑制基因1基因表达的降低,而miR16-5p过表达细胞显示出表达的增加。这些发现可能表明miR-16-5p是转录后调节ADP核糖基化因子样肿瘤抑制基因1表达的直接调控微小RNA,它可能是该基因在癌症中下调的原因。
{"title":"The Role and Antagonistic Effects of miR-16-5p in the Regulation of ADP-Ribosylation Factor-Like Tumor Suppressor Gene 1 in Lung Cancer Cells.","authors":"Tuğba Nurcan Yüksel, Esra Bozgeyik, İbrahim Bozgeyik","doi":"10.5152/eurasianjmed.2023.23073","DOIUrl":"10.5152/eurasianjmed.2023.23073","url":null,"abstract":"<p><strong>Objective: </strong>ADP-ribosylation factor-like tumor suppressor gene 1 is a member of the Ras superfamily of small guanosine triphosphatases that are known to be involved in multiple regulatory pathways in the multistage development of human cancers. Also, ADP-ribosylation factor-like tumor suppressor gene 1 expression levels have been reported to be dramatically lower in both cancer cell lines and tumor tissues compared to controls. Accordingly, defects in the regulation of the ADP-ribosylation factor-like tumor suppressor gene 1 gene seems have key tumor suppressive effects in the formation and development of human cancers including lung cancer. Moreover, microRNAs regulating the expression of ADP-ribosylation factor-like tumor suppressor gene 1 have not been described previously. Accordingly, the present study aimed to reveal the influence of miR-16-5p on the regulation of ADP-ribosylation factor-like tumor suppressor gene 1 gene.</p><p><strong>Materials and methods: </strong>A549 lung adenocarcinoma cells were used. For the overexpression and silencing experiments of miR-16-5p synthetic microRNA mimics and inhibitors were used, respectively. Gene expression analyses were achieved with the help of quantitative real-time polymerase chain reaction.</p><p><strong>Results: </strong>MiR-16-5p was identified to be predictive target of ADP-ribosylation factor-like tumor suppressor gene 1 and directly targets the expression of ADP-ribosylation factor-like tumor suppressor gene 1 as revealed by the overexpression and silencing experiments. Specifically, it was found that miR-16-5p-overexpressed A549 cells showed a decrease in ADP-ribosylation factor-like tumor suppressor gene 1 gene expression, whereas miR16-5p-suppressed cells showed an increase in expression. These findings possibly suggest that miR-16-5p is the direct regulatory microRNA that posttranscriptionally regulates the expression of ADP-ribosylation factor-like tumor suppressor gene 1.</p><p><strong>Conclusion: </strong>Collectively, miR-16-5p seems to be a key regulatory molecule involved in the posttranscriptional regulation of the ADP-ribosylation factor-like tumor suppressor gene 1, and it might be responsible for the downregulation of this gene in lung cancer.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"55 3","pages":"204-207"},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eurasian Journal of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1